Israeli clinical AI Aidoc today announced the launch of its first and only AI technology to identify suspected posterior and anterior large and medium vessel occlusions, strokes, aneurysms, and hemorrhages.
The Full Brain Solution for vessel occlusions is the first and only AI technology to identify suspected posterior and anterior LVOs and MeVOs. This is a significant advancement, as these conditions are often difficult to diagnose and can lead to serious complications if not treated quickly.
Strokes in the United States
- Every year, about 795,000 strokes occur in the United States.
- Of these, about 87% are ischemic strokes.
- About 25-40% of ischemic strokes are medium vessel occlusions (MeVOs).
- About 24-46% of all ischemic strokes are large vessel occlusions (LVOs).
- About 20-25% of LVOs are posterior.
What are MeVOs and LVOs?
- MeVOs are strokes that occur when a blood clot blocks a medium-sized artery in the brain.
- LVOs are strokes that occur when a blood clot blocks a large-sized artery in the brain.
- Posterior LVOs are strokes that occur in the back of the brain.
The importance of early diagnosis and treatment
- Strokes are a medical emergency.
- Early diagnosis and treatment are essential for improving outcomes.
- The Full Brain Solution from Aidoc can help to identify patients with strokes faster, leading to improved outcomes.
Adding posterior LVO and MeVO to the Full Brain Solution means that approximately twice as many patients can now receive faster access to life-saving therapy. This is a significant step forward in the fight against strokes and is expected to impact patient outcomes significantly.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
The Full Brain Solution is delivered through Aidoc’s proprietary operating system aiOS, which enables organizations to deploy AI solutions at scale reliably. The aiOS seamlessly integrates with existing IT infrastructure, making it easy to implement and use.
“We are excited to launch the Full Brain Solution, which represents a significant advancement in our mission to improve patient care,” said Elad Walach, CEO of Aidoc. “This new solution will help save lives and improve outcomes for stroke patients.”
The Full Brain Solution is currently available in the United States and is expected to be rolled out in other countries in the coming months.
AiDoc analyzes and aggregates medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient.
Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (13) in clinical AI, and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data.
